查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
临床前 CRO 全球市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1267312

临床前 CRO 全球市场研究报告 - 2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Preclinical CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

全球对临床前 CRO 市场的需求将从 2022 年的 90.9 亿美元增长到 2030 年的近 209.8 亿美元，预计 2023-2030 年研究期间的复合年增长率为 11.02%

临床前 CRO(合同研究组织)是主要在製药、生物技术和医疗设备领域提供研究和测试服务的公司。 这些服务通常在药物开发的临床前阶段进行，即新药在人体临床试验中进行测试之前的时期。 临床前 CRO 服务包括范围广泛的活动，包括实验室测试、动物测试和毒理学测试。 临床前 CRO 公司通常拥有专门的实验室和设施，以及训练有素且精通各种科学学科的员工。

市场动态：

预计对新药和医疗器械的监管要求不断提高将提振市场。 新药开发是一个漫长而昂贵的过程，需要大量的资源和专业知识。 製药公司、生物技术公司和医疗设备製造商通常发现将部分研发外包给专业的 CRO 更具成本效益，这有望推动市场增长。 此外，对新药和医疗的需求不断增长正在推动市场增长。 CRO 在新药和医疗器械的开发中发挥着关键作用，有助于确保药物在上市前的安全性和有效性。 然而，在研发过程中使用动物可能会阻碍市场增长。

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。 这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。 此外，这些工具还能够全面评估全球临床前CRO市场的各个细分市场。 临床前 CRO 行业的发展和趋势为这项研究提供了一种整体方法。

市场细分：

本部分按国家/地区提供详细的细分数据，以帮助您确定每种产品/服务的目标受众和未来商机。

按服务

  • 生物分析和 DMPK 测试(体外 ADME，体内 PK)
  • 毒理学测试(GLP、非 GLP)
  • 化合物管理(工艺研发、定制合成等)
  • 化学(药物化学、计算化学)
  • 安全药理学
  • 其他

按模型类型

  • 患者衍生的有机体 (PDO) 模型
  • 患者来源的异种移植模型

按最终用途

  • 生物製药公司
  • 政府/学术机构
  • 医疗设备製造商

按地区分析：

本节涵盖区域展望，重点关注北美、欧洲、亚太地区、拉丁美洲、中东和非洲临床前 CRO 市场当前和未来的需求。 此外，它还侧重于所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。 临床前 CRO 市场的主要参与者是 SGS SA (SGS)、Charles River Laboratories International Inc.、Eurofins Scientific、PRA Health Sciences Inc.、Wuxi AppTec、Medpace Inc.、Pharmaceutical Product Development (PPD) LLC、Intertek Group Plc ( IGP ), Crown Bioscience, Laboratory Corporation of America Inc. 本节概述了竞争格局，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。它包括的大局。

内容

第1章前言

  • 报告内容
    • 目的
    • 目标受众
    • USP(独特的销售建议)及其提供的内容
  • 调查范围
  • 调查方法
    • 市场调研流程
    • 市场研究方法

第 2 章执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章临床前 CRO - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场製约因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按服务分类的市场吸引力分析
    • 按模型类型进行市场吸引力分析
    • 按最终用途进行的市场吸引力分析
    • 市场吸引力分析：按地区

第四章价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料製造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 市场发展趋势

第 5 章 COVID-19 爆发的影响分析

第 6 章临床前 CRO 全球市场分析：按服务分类

  • 服务概览
  • 过去和未来的数据
  • 服务分析
  • 生物分析和 DMPK 测试(体外 ADME、体内 PK)
  • 毒理学测试(GLP、非 GLP)
  • 化合物管理(工艺研发、定制合成等)
  • 化学(药物化学、计算化学)
  • 安全药理学
  • 其他

第 7 章临床前 CRO 全球市场分析：按模型类型分类

  • 按模型类型概述
  • 过去和未来的数据
  • 按模型类型分析
  • 患者衍生的有机体 (PDO) 模型
  • 患者来源的异种移植模型

第 8 章全球临床前 CRO 市场销售分析(按最终用途)

  • 最终用户总结
  • 过去和未来的数据
  • 最终用户分析
  • 生物製药公司
  • 政府/学术机构
  • 医疗设备製造商

第 9 章按地区分列的全球临床前 CRO 市场销售分析

  • 按地区进行的销售前景分析
  • 介绍销售分析
  • 北美销售分析
    • 概览、历史和预测销售分析
    • 北美各部门的销售分析
    • 北美销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史和预测销售分析
    • 按细分市场进行的欧洲销售分析
    • 按国家/地区划分的欧洲销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 其他欧洲销售分析
  • 亚太地区销售分析
    • 概览、历史和预测销售分析
    • 亚太地区各部门的销售分析
    • 亚太国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本的销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 其他亚太地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史和预测销售分析
    • 拉丁美洲各部门的销售分析
    • 拉丁美洲国家/地区的销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利的销售分析
    • 其他拉丁美洲销售分析
  • 中东和非洲销售分析
    • 概览、历史和预测销售分析
    • 中东和非洲各细分市场的销售额分析
    • 中东和非洲国家/地区的销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 其他中东和非洲销售分析

第10章临床前CRO公司的竞争格局

  • 临床前 CRO 市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他扩展

第11章公司简介

  • 前 10 名公司的市场份额分析
  • 市场集中度
  • SGS SA (SGS)
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 查尔斯河实验室国际公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 欧陆科学
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • PRA 健康科学公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 无锡艾普泰克
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 美佩斯公司
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 医药产品开发 (PPD) LLC
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 天祥集团 (IGP)
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势
  • 美国公司 Crown Bioscience and Laboratory Corporation
    • 公司概况
    • 企业收入
    • 产品介绍
    • 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

Product Code: VMR112110008

The global demand for Preclinical CRO Market is presumed to reach the market size of nearly USD 20.98 BN by 2030 from USD 9.09 BN in 2022 with a CAGR of 11.02% under the study period 2023 - 2030.

A preclinical CRO, or contract research organization, is a company that provides research and testing services to industries mainly in the field of pharmaceutical, biotechnology, and medical devices. These services are typically conducted during the preclinical stage of drug development, which refers to the period before a new drug is tested in human clinical trials. Preclinical CRO services can include a wide range of activities, such as laboratory testing, animal testing, and toxicology studies. Preclinical CRO companies typically have specialized laboratories and equipment and highly trained staff with expertise in various scientific fields.

Market Dynamics:

The increasing regulatory requirements for new drugs and medical devices are expected to raise the market. The development of a new drug is a long, expensive process that requires significant resources and expertise. Pharma, biotech, and medical device manufacturers often find it more cost-effective to outsource certain aspects of their research and development efforts to specialized CROs, which may drive market growth.Moreover, the increasing demand for new drugs and medical treatments boosts market growth. These companies play a vital role in developing new medicines and medical devices, assisting in ensuring the safety and effectiveness of the medicine before it is available to the public. However, the use of animals in the research and development process may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preclinical cro. The growth and trends of preclinical cro industry provide a holistic approach to this study.

Market Segmentation:

This section of the preclinical cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

  • Bioanalysis And Dmpk Studies (In Vitro ADME, In-Vivo PK)
  • Toxicology Testing (GLP, Non-GLP)
  • Compound Management (Process R&D, Custom Synthesis, Others)
  • Chemistry (Medicinal Chemistry, Computation Chemistry)
  • Safety Pharmacology
  • Others

By Model Type

  • Patient Derived Organoid (PDO) Model
  • Patient Derived Xenograft Model

By End-Use

  • Biopharmaceutical Companies
  • Government And Academic Institutes
  • Medical Device Companies

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Preclinical CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preclinical cro market include SGS SA (SGS), Charles River Laboratories International Inc., Eurofins Scientific, PRA Health Sciences Inc., Wuxi AppTec, Medpace Inc., Pharmaceutical Product Development (PPD) LLC, Intertek Group Plc (IGP), Crown Bioscience and Laboratory Corporation of America Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PRECLINICAL CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service
    • 3.7.2 Market Attractiveness Analysis By Model Type
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY SERVICE

  • 6.1 Overview by Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Service
  • 6.4 Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Historic and Forecast Sales by Regions
  • 6.5 Toxicology Testing (GLP, Non-GLP) Historic and Forecast Sales by Regions
  • 6.6 Compound Management (Process R&D, Custom Synthesis, Others) Historic and Forecast Sales by Regions
  • 6.7 Chemistry (Medicinal Chemistry, Computation Chemistry) Historic and Forecast Sales by Regions
  • 6.8 Safety Pharmacology Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY MODEL TYPE

  • 7.1 Overview by Model Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Model Type
  • 7.4 Patient Derived Organoid (PDO) Model Historic and Forecast Sales by Regions
  • 7.5 Patient Derived Xenograft Model Historic and Forecast Sales by Regions

8 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Biopharmaceutical Companies Historic and Forecast Sales by Regions
  • 8.5 Government And Academic Institutes Historic and Forecast Sales by Regions
  • 8.6 Medical Device Companies Historic and Forecast Sales by Regions

9 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PRECLINICAL CRO COMPANIES

  • 10.1. Preclinical Cro Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF PRECLINICAL CRO INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. SGS SA (SGS)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Charles River Laboratories International Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Eurofins Scientific
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. PRA Health Sciences Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Wuxi AppTec
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Medpace Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Pharmaceutical Product Development (PPD) LLC
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Intertek Group Plc (IGP)
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Crown Bioscience and Laboratory Corporation of America Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service (USD MN)
  • Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Market Sales by Geography (USD MN)
  • Toxicology Testing (GLP, Non-GLP) Market Sales by Geography (USD MN)
  • Compound Management (Process R&D, Custom Synthesis, Others) Market Sales by Geography (USD MN)
  • Chemistry (Medicinal Chemistry, Computation Chemistry) Market Sales by Geography (USD MN)
  • Safety Pharmacology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Model Type (USD MN)
  • Patient Derived Organoid (PDO) Model Market Sales by Geography (USD MN)
  • Patient Derived Xenograft Model Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Government And Academic Institutes Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Global Preclinical Cro Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Preclinical Cro Report
  • Market Research Process
  • Market Research Methodology
  • Global Preclinical Cro Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Model Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service (USD MN)
  • Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Market Sales by Geography (USD MN)
  • Toxicology Testing (GLP, Non-GLP) Market Sales by Geography (USD MN)
  • Compound Management (Process R&D, Custom Synthesis, Others) Market Sales by Geography (USD MN)
  • Chemistry (Medicinal Chemistry, Computation Chemistry) Market Sales by Geography (USD MN)
  • Safety Pharmacology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Model Type (USD MN)
  • Patient Derived Organoid (PDO) Model Market Sales by Geography (USD MN)
  • Patient Derived Xenograft Model Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biopharmaceutical Companies Market Sales by Geography (USD MN)
  • Government And Academic Institutes Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.